"I am always in tune with the 'best of' and 'must-watch' stock lists. Most recently, Canopy Growth, the worlds' largest cannabis producer, has caught my eye. As cannabis becomes legalized in many areas of the world and is used medically more and more, the company is expanding to Germany, Spain, Denmark, and Australia. What ups the ante is that Canopy Growth is in partnership with an alcoholic beverage company. This partnership gives them a significant advantage when cannabis-based beer and other alcoholic beverages become mainstream."

"I tend to keep a considerable amount of interest in medical and pharma and so, for that reason, I believe looking into Gilead would be very lucrative. The drugmaker helped turn HIV from a fatal disease into a manageable chronic ailment and developed a cure for Hepatitic C. They have become a 100B company along the way, and there is a lot of buzz surrounding a change in leadership which is sure to produce even bigger results in the years to come."